These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 16945059

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Ziprasidone-associated depressive state in schizophrenic patients.
    Kaptsan A, Dwolatzky T, Lerner V.
    Clin Neuropharmacol; 2007; 30(6):357-61. PubMed ID: 18090461
    [Abstract] [Full Text] [Related]

  • 3. High-dose ziprasidone-induced acute dystonia.
    Rosenfield PJ, Girgis RR, Gil R.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar 30; 31(2):546-7. PubMed ID: 17123682
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Ziprasidone-associated pedal edema in the treatment of schizophrenia.
    Ku HL, Su TP, Chou YH.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jul 30; 30(5):963-4. PubMed ID: 16624468
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Urticaria and angio-oedema due to ziprasidone.
    Akkaya C, Sarandol A, Aydogan K, Kirli S.
    J Psychopharmacol; 2007 Jul 30; 21(5):550-2. PubMed ID: 17446198
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Ziprasidone- and lithium-induced neuroleptic malignant syndrome.
    Borovicka MC, Bond LC, Gaughan KM.
    Ann Pharmacother; 2006 Jan 30; 40(1):139-42. PubMed ID: 16352776
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Ziprasidone-induced hypersensitivity syndrome in an aged schizophrenia patient.
    Tsai CF, Tsai SJ, Hwang JP.
    Int J Geriatr Psychiatry; 2005 Aug 30; 20(8):797-9. PubMed ID: 16035110
    [No Abstract] [Full Text] [Related]

  • 18. Ziprasidone outcome and tolerability: a practical clinical trial with plasma drug levels.
    Mauri MC, Colasanti A, Rossattini M, Volonteri LS, Dragogna F, Fiorentini A, Fiorentini A, Valli A, Papa P.
    Pharmacopsychiatry; 2007 May 30; 40(3):89-92. PubMed ID: 17541882
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.